about
A protease for 'middle-down' proteomicsProgress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsSystems Proteomics View of the Endogenous Human Claudin Protein FamilyIon Activation Methods for Peptides and ProteinsAnalysis of Monoclonal Antibody Sequence and Post-translational Modifications by Time-controlled Proteolysis and Tandem Mass Spectrometry.The next level of complexity: crosstalk of posttranslational modifications.Principles of electron capture and transfer dissociation mass spectrometry applied to peptide and protein structure analysis.Comprehending dynamic protein methylation with mass spectrometryCharacterization of green fluorescent proteins by 193 nm ultraviolet photodissociation mass spectrometry.Proteomic identification and analysis of K63-linked ubiquitin conjugatesProtein analysis by shotgun/bottom-up proteomicsPreparing to read the ubiquitin code: a middle-out strategy for characterization of all lysine-linked diubiquitins.Mass-biased partitioning to enhance middle down proteomics analysisThe proteomic future: where mass spectrometry should be taking us.Unraveling the different proteomic platforms.High-resolution MS for structural characterization of protein therapeutics: advances and future directions.Ultraviolet photodissociation for characterization of whole proteins on a chromatographic time scale.Proteome-Wide Protein Expression Profiling Across Five Pancreatic Cell Lines.Mining the fecal proteome: from biomarkers to personalised medicine.Top-Down Mass Spectrometry: Proteomics to Proteoforms.Toward an Optimized Workflow for Middle-Down Proteomics.Hybridizing ultraviolet photodissociation with electron transfer dissociation for intact protein characterization.Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry.Complete Characterization of Cardiac Myosin Heavy Chain (223 kDa) Enabled by Size-Exclusion Chromatography and Middle-Down Mass Spectrometry.Systematic quantitative analysis of H2A and H2B variants by targeted proteomics.Limited proteolysis in porous membrane reactors containing immobilized trypsin.
P2860
Q24609943-CC0350F5-526B-4FA2-9DAD-53B5D1C173DCQ26781745-B8A7A8E3-6B93-47A9-8741-39F188C36E13Q28271194-7D66AB30-836B-4615-8751-4945A8E900FDQ29391863-09AE5642-3A9B-43DD-99F4-2151B3F12330Q30277986-00C721CC-7C02-488D-A8EC-76661B4C9367Q30356852-CC1BFDB8-9256-4B8F-9230-6746E0407D1BQ30427725-126CCD56-E99C-4C4E-9B3F-179159CA5303Q33746178-D319C08B-F97F-456B-B0B8-EA7A1B2EE416Q33809034-77599352-3CE7-4883-AE0D-DB57C58B8E26Q34458413-148F8A16-3F3F-4FC1-B1DF-F7454FD4648FQ34600986-E1609A98-CCA9-4FE9-8BC1-0E9281DA48C2Q34650330-F4ADA71C-9938-4EFB-8FE4-42E72A3CC3A0Q36700632-93C23144-45EF-4F61-BA51-4D9AD2E92586Q38009054-35B62806-CAE2-43F4-BCC3-983CDA87628FQ38065125-32CA59AC-6071-4725-A0E8-BD65C845D186Q38110611-862AAD66-02C5-4642-A380-C0689B579C9EQ38330812-D1CBB3CC-B6C1-4F4F-8C20-4E5CE92436D6Q38708989-55B1AE1B-3BA9-49CA-BBA3-162A09BB18F2Q38865393-187E5F11-1CAE-45DD-A2A2-C4C7D4B3A457Q39038792-E1EF0109-EE0C-4F5F-A44C-A7684328FBC1Q41959398-B1DFDB77-5C2A-4299-B726-1EE6C6ED0707Q42980459-072945D8-FDF5-4E0B-A8F7-F1C1942CEA9CQ44205132-E54799BC-E96F-4391-967C-CBCD2E99BBB7Q47224273-185ABA84-AF38-4DE9-BF40-BF5EC692D72EQ48539829-510ABB7C-929C-40A0-BF15-F066054BE3F7Q50947729-35EDF321-7DB1-4DF4-B133-18EACB36C3CE
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
High-throughput middle-down analysis using an orbitrap
@en
High-throughput middle-down analysis using an orbitrap.
@nl
type
label
High-throughput middle-down analysis using an orbitrap
@en
High-throughput middle-down analysis using an orbitrap.
@nl
prefLabel
High-throughput middle-down analysis using an orbitrap
@en
High-throughput middle-down analysis using an orbitrap.
@nl
P2093
P2860
P356
P1476
High-throughput middle-down analysis using an orbitrap
@en
P2093
Catherine Fenselau
Colin Wynne
Joe Cannon
Karen Lohnes
Nathan Edwards
P2860
P304
P356
10.1021/PR1000994
P50
P577
2010-08-01T00:00:00Z